Although several retrospective studies have demonstrated the efficacy of transplantation in AML patients with TP53 mutations [38,39], outcomes remain unsatisfactory, and no prospective studies have been conducted to evaluate transplant effectiveness. The gene discussed is TP53; the disease is acute myeloid leukemia.